Search Chat Visualize Browse

Hypothesis Results Question Article Posters Peer Review CV+

/CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.

Articles (10)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.